Your browser doesn't support javascript.
loading
A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease.
Serratrice, Christine; Stirnemann, Jérôme; Berrahal, Amina; Belmatoug, Nadia; Camou, Fabrice; Caillaud, Catherine; Billette de Villemeur, Thierry; Dalbies, Florence; Cador, Bérengère; Froissart, Roseline; Masseau, Agathe; Brassier, Anaïs; Hivert, Bénédicte; Swiader, Laure; Bertchansky, Ivan; de Moreuil, Claire; Chabrol, Brigitte; Durieu, Isabelle; Leguy Seguin, Vanessa; Astudillo, Leonardo; Humbert, Sébastien; Pichard, Samia; Marcel, Catherine; Hau Rainsard, Isabelle; Bengherbia, Monia; Yousfi, Karima; Berger, Marc G.
Affiliation
  • Serratrice C; Department of Internal Medicine for the Aged, Geneva University Hospitals, 1226 Thonex- Geneva, Switzerland.
  • Stirnemann J; Department of Internal Medicine, Department of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
  • Berrahal A; University Hospital of Clermont Ferrand, Hematology Biology Department, 63000 Clermont-Ferrand, France.
  • Belmatoug N; Department of Internal Medicine, Centre de Référence des Maladies Lysosomales, AP-HP.Nord, Site Beaujon, Paris University, 92110 Clichy, France.
  • Camou F; Intensive Care Unit, Hôpital Saint-André, CHU Bordeaux, 33000 Bordeaux, France.
  • Caillaud C; Biochemistry, Metabolomics, and Proteomics Department, Necker Enfants Malades University Hospital, AP-HP, Center-Paris University, 75015 Paris, France.
  • Billette de Villemeur T; Department of Pediatric Neurology, Hôpital Trousseau, AP-HP, 75012 Paris, France.
  • Dalbies F; Institute of Cancerology and Hematology, CHRU Morvan, 29200 Brest, France.
  • Cador B; Department of Internal Medicine, CHU Pontchaillou, 35000 Rennes, France.
  • Froissart R; Biochemical and Molecular Biology Department, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69500 Bron, France.
  • Masseau A; Department of Internal Medicine, CHU Hôtel Dieu, 44093 Nantes, France.
  • Brassier A; Reference Centre for Hereditary Metabolic Diseases, Hôpital Necker-Enfants Malades, AP-HP, IHU Institut Imagine, 75015 Paris, France.
  • Hivert B; Department of Clinical Hematology, Hôpital Saint Vincent de Paul, Groupement des Hôpitaux de l'Institut Catholique de Lille, 59800 Lille, France.
  • Swiader L; Department of Internal Medicine, CHU Timone, 13005 Marseille, France.
  • Bertchansky I; Department of Internal Medicine, Saint-Eloi Hospital, CHU Montpellier, 34000 Montpellier, France.
  • de Moreuil C; Department of Internal Medicine, Hôpital de la Cavale Blanche, CHRU de Brest, 29200 Brest, France.
  • Chabrol B; Department of Pediatric Neurology, CHU Timone, 13005 Marseille, France.
  • Durieu I; Department of Internal Medicine, Hospices Civils de Lyon, University Claude Bernard Lyon 1, 69495 Pierre-Bénite, France.
  • Leguy Seguin V; Department of Internal Medicine and Clinical Immunology, CHU F. Mitterrand, 21000 Dijon, France.
  • Astudillo L; Department of Internal Medicine, CHU Toulouse, 31300 Toulouse, France.
  • Humbert S; Department of Internal Medicine, Besancon University Hospital, 25000 Besancon, France.
  • Pichard S; Service of Metabolic Diseases, Hôpital Robert Debré, 75019 Paris, France.
  • Marcel C; Department of Internal Medicine, Centre de Référence des Maladies Lysosomales, AP-HP.Nord, Site Beaujon, Paris University, 92110 Clichy, France.
  • Hau Rainsard I; Service of General Pediatry, CHI Créteil, 94000 Créteil, France.
  • Bengherbia M; Department of Internal Medicine, Centre de Référence des Maladies Lysosomales, AP-HP.Nord, Site Beaujon, Paris University, 92110 Clichy, France.
  • Yousfi K; Department of Internal Medicine, Centre de Référence des Maladies Lysosomales, AP-HP.Nord, Site Beaujon, Paris University, 92110 Clichy, France.
  • Berger MG; University Hospital of Clermont Ferrand, Hematology Biology Department, 63000 Clermont-Ferrand, France.
J Clin Med ; 9(8)2020 Jul 22.
Article in En | MEDLINE | ID: mdl-32708003
ABSTRACT
Patients with type 1 Gaucher disease (GD1) present thrombocytopenia, anemia, organomegaly, and bone complications. Most experts consider that the less aggressive forms do not require specific treatment. However, little is known about the disease course of these forms. The objective of this cross-sectional retrospective study was to compare the clinical, radiological, and laboratory characteristics of patients with less severe GD1 at diagnosis and at the last evaluation to identify features that might lead to potential complications. Non-splenectomized and never-treated patients (19 women and 17 men) were identified in the French Gaucher Disease Registry (FGDR). Their median age was 36.6 years (2.4-75.1), and their median follow-up was 7.8 years (0.4-32.4). Moreover, 38.7% were heterozygous for the GBA1 N370S variant, and 22.6% for the GBA1 L444P variant. From diagnosis to the last evaluation, GD1 did not worsen in 75% of these patients. Some parameters improved (fatigue and hemoglobin concentration), whereas platelet count and chitotriosidase level remained stable. In one patient (2.7%), Lewy body dementia was diagnosed at 46 years of age. Bone lesion onset was late and usually a single event in most patients. This analysis highlights the genotypic heterogeneity of this subgroup, in which disease could remain stable and even improve spontaneously. It also draws attention to the possible risk of Lewy body disease and late onset of bone complications, even if isolated, to be confirmed in larger series and with longer follow-up.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Med Year: 2020 Document type: Article Affiliation country: Switzerland Publication country: CH / SUIZA / SUÍÇA / SWITZERLAND

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Med Year: 2020 Document type: Article Affiliation country: Switzerland Publication country: CH / SUIZA / SUÍÇA / SWITZERLAND